Chemical Management

2022 chemical industry outlook

April 14, 2022

2022 chemical
The US chemical industry has witnessed a strong
recovery since the beginning of 2021, with demand
increasing from the major end markets such as
construction and health and safety.

Spotlight

Neurocrine Biosciences

Neurocrine Biosciences, Inc of San Diego is a product-based biopharmaceutical company focusing on the development and commercialization of innovative pharmaceutical products to treat unmet medical needs. The Company's research and development efforts are focused on neurological and endocrine diseases and disorders. Our product candidates address some of the largest pharmaceutical markets in the world including endometriosis, irritable bowel syndrome, anxiety, depression, pain, diabetes, insomnia, and other neurological and endocrine related diseases and disorders. We are committed to bringing new innovative treatments through development to deliver new hope to patients and their loved ones.

OTHER WHITEPAPERS
news image

Decarbonizing the Canadian Chemical and Fertilizer Industry

whitePaper | March 11, 2023

Canada’s economy and the lives of Canadians are highly reliant on the materials and products produced by the chemical and fertilizer industry.

Read More
news image

Coordination Compounds

whitePaper | May 15, 2022

In the previous Unit we learnt that the transition metals form a large number of complex compounds in which the metal atoms are bound to a number of anions or neutral molecules by sharing of electrons.

Read More
news image

White Paper on the Low-carbon Development of the Petrochemical Industry

whitePaper | April 22, 2022

As the impacts of climate change increase, China announced the goal of "striving to peak CO2 emissions by 2030 and achieve carbon neutrality by 2060".

Read More
news image

Liability and Coverage for the “Forever Chemicals”

whitePaper | May 11, 2022

For decades, BatesCarey has litigated insurance coverage disputes involving nationwide environmental pollution claims arising from an ever-evolving recognition of the toxicity of<br /> everyday products once thought to be innocuous, or even beneficial to society.

Read More
news image

Decarbonizing practices in the global chemical industry

whitePaper | December 23, 2022

This white paper examines the current state and trajectory of decarbonization within the global chemicals industry. By examining and establishing a baseline on industry action.

Read More
news image

PLASTIC FOR PROFIT

whitePaper | July 12, 2021

The author wishes to thank Willie Wilson for his advice and support with stakeholder mapping throughout the project, Linh Tran Phuong Dang for helping with research and data collection, and many individuals and organizations that have shared their knowledge, including INTERPOL’s Pollution Crime Working Group; the environmental agencies of the United Kingdom, Zambia, Ghana and South Africa; the Environment and Natural Resources Division at the United States Department of Justice;

Read More

Spotlight

Neurocrine Biosciences

Neurocrine Biosciences, Inc of San Diego is a product-based biopharmaceutical company focusing on the development and commercialization of innovative pharmaceutical products to treat unmet medical needs. The Company's research and development efforts are focused on neurological and endocrine diseases and disorders. Our product candidates address some of the largest pharmaceutical markets in the world including endometriosis, irritable bowel syndrome, anxiety, depression, pain, diabetes, insomnia, and other neurological and endocrine related diseases and disorders. We are committed to bringing new innovative treatments through development to deliver new hope to patients and their loved ones.

Events